ZA881239B - Canine distemper virus vaccine - Google Patents

Canine distemper virus vaccine

Info

Publication number
ZA881239B
ZA881239B ZA881239A ZA881239A ZA881239B ZA 881239 B ZA881239 B ZA 881239B ZA 881239 A ZA881239 A ZA 881239A ZA 881239 A ZA881239 A ZA 881239A ZA 881239 B ZA881239 B ZA 881239B
Authority
ZA
South Africa
Prior art keywords
canine distemper
distemper virus
virus vaccine
virus
vaccine
Prior art date
Application number
ZA881239A
Other languages
English (en)
Inventor
P. Bass Edmund
H. Kelsey William
D. Mcfarland Michael
Original Assignee
Diamond Scientific Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21817338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA881239(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Diamond Scientific Co. filed Critical Diamond Scientific Co.
Publication of ZA881239B publication Critical patent/ZA881239B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18461—Methods of inactivation or attenuation
    • C12N2760/18463—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA881239A 1987-03-09 1988-02-23 Canine distemper virus vaccine ZA881239B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2381487A 1987-03-09 1987-03-09

Publications (1)

Publication Number Publication Date
ZA881239B true ZA881239B (en) 1988-08-17

Family

ID=21817338

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881239A ZA881239B (en) 1987-03-09 1988-02-23 Canine distemper virus vaccine

Country Status (6)

Country Link
EP (2) EP0282179B1 (fr)
JP (1) JPS63277633A (fr)
AT (1) ATE122235T1 (fr)
CA (1) CA1337268C (fr)
DE (1) DE3853736T2 (fr)
ZA (1) ZA881239B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4136900C1 (fr) * 1991-11-09 1993-07-29 Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De
IL104382A0 (en) * 1992-01-17 1993-05-13 Solvay Animal Health Inc Vaccine containing acemannan as an adjuvant
ATE220327T1 (de) 1992-09-29 2002-07-15 Inhale Therapeutic Syst Pulmonale abgabe von aktiven fragmenten des parathormons
ES2218543T3 (es) 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7442388B2 (en) 2000-05-10 2008-10-28 Weers Jeffry G Phospholipid-based powders for drug delivery
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
US4545987A (en) * 1983-12-20 1985-10-08 Advanced Genetics Research Institute Psoralen inactivated double-stranded RNA viral vaccines

Also Published As

Publication number Publication date
EP0506147A2 (fr) 1992-09-30
AU614735B2 (en) 1991-09-12
CA1337268C (fr) 1995-10-10
DE3853736T2 (de) 1995-09-28
EP0506147A3 (fr) 1992-10-21
AU1176088A (en) 1988-09-08
ATE122235T1 (de) 1995-05-15
DE3853736D1 (de) 1995-06-14
EP0282179A3 (en) 1990-01-31
EP0282179A2 (fr) 1988-09-14
EP0282179B1 (fr) 1995-05-10
JPS63277633A (ja) 1988-11-15

Similar Documents

Publication Publication Date Title
EP0282179A3 (en) Canine distemper virus vaccine
MX9306841A (es) Vacuna a base de ureasa contra la infeccion por helicobacter en mamiferos.
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
AU3188989A (en) Virally modified tumour vaccines for immunotherapy of tumour metastases
NZ192477A (en) Method for protecting dogs against virulent canine parvovirus using inactivated virus vaccine
AU7763294A (en) Live in ovo vaccine
SG73999A1 (en) Hepatitis a virus vaccines
HU9202976D0 (en) Vaccine acting against anaemy of chicken
ES500199A0 (es) Un procedimiento para preparar una vacuna de virus de la ra-bia inactivados
DK0626008T3 (da) Vaccine, der som en adjuvans indeholder acemannan
DZ1550A1 (fr) Vaccin depourvu de cellules contre le virus de la maladie marek.
AR016987A1 (es) Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a
ATE16348T1 (de) Ozon-inaktivierte keime als vakzine.
ES2068883T3 (es) Vacunas combinadas vivas.
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
ES515472A0 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
EP0485463A4 (en) Attenuated canine parvovirus (cpv), vaccine comprising cpv and method of preventing infection by cpv in dogs
DE10199014I2 (de) Impfstoff
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
ES482549A0 (es) Un metodo para la preparacion de una composicion de virus herpes
SU1565027A1 (ru) Инактиватор вируса западного нила
Dardanoni et al. Vaccination against hepatitis B: Evaluation of the prevaccination markers.
IT1102591B (it) Composizione stabilizzante per vaccini
NL7803891A (en) Preservatives for vaccines - contg. hydrolysed gelatin, sorbitol, culture medium and a buffer at pH 6-6.5